Cyclopharm Limited
Research Cyclopharm Limited (CYC.AX) on Bullrun: market cap AUD 50.29M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCYC.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 50.29M
- Financial periodFY2025
- RevenueAUD 16.69M
- Revenue growth-39.5%
- Net income-AUD 17.22M
- Free cash flow-AUD 19.44M
- Gross margin13.3%
Valuation Snapshot
latest market cap is AUD 50.29M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 16.69M | -AUD 17.22M | -AUD 19.44M | 13.3% | -0.16 | AUD 6.63M | AUD 7.74M | AUD 27.11M |
| FY2024 | AUD 27.57M | -AUD 13.20M | -AUD 13.55M | 65.0% | -0.13 | AUD 20.57M | AUD 8.29M | AUD 42.73M |
| FY2023 | AUD 26.34M | -AUD 4.70M | -AUD 7.71M | 61.1% | -0.05 | AUD 11.73M | AUD 4.23M | AUD 32.26M |
| FY2022 | AUD 23.22M | -AUD 6.61M | -AUD 8.21M | 68.0% | -0.07 | AUD 20.30M | AUD 4.33M | AUD 36.54M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 50.29M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
| Year | Dividends/share |
|---|---|
| FY2023 | 0.01 AUD |
| FY2022 | 0.01 AUD |
About Cyclopharm Limited
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cyclopharm Limited's market cap?
Cyclopharm Limited's market capitalization is AUD 50.29M.
What does Cyclopharm Limited do?
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.